OWA
ABBV icon

Outlook Wealth Advisors’s AbbVie ABBV Stock Holding History

Outlook Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$327K Sell
1,301
-40
-3% -$8.61K 0.07% 239
2026
Q1 		$292K Buy
1,341
+60
+5% +$13.3K 0.07% 258
2025
Q4 		$293K Buy
1,281
+100
+8% +$22.8K 0.07% 246
2025
Q3 		$273K Sell
1,181
-56
-5% -$11.4K 0.07% 249
2025
Q2 		$230K Buy
1,237
+56
+5% +$10.4K 0.06% 258
2025
Q1 		$247K Hold
1,181
– – 0.07% 244
2024
Q4 		$210K Sell
1,181
-50
-4% -$9.19K 0.06% 245
2024
Q3 		$243K Buy
1,231
+38
+3% +$7.09K 0.07% 234
2024
Q2 		$205K Sell
1,193
-50
-4% -$8.28K 0.06% 252
2024
Q1 		$226K Sell
1,243
-408
-25% -$70.3K 0.07% 243
2023
Q4 		$256K Buy
1,651
+86
+5% +$12.5K 0.09% 190
2023
Q3 		$233K Hold
1,565
– – 0.09% 181
2023
Q2 		$211K Buy
+1,565
New +$229K 0.08% 190
2023
Q1 		– Sell
-1,540
Closed -$249K – 180
2022
Q4 		$249K Sell
1,540
-20
-1% -$3.07K 0.12% 150
2022
Q3 		$210K Sell
1,560
-26
-2% -$3.73K 0.09% 172
2022
Q2 		$243K Sell
1,586
-19
-1% -$2.9K 0.1% 165
2022
Q1 		$261K Buy
+1,605
New +$233K 0.09% 172
2020
Q4 		– Sell
-2,578
Closed -$226K – 182
2020
Q3 		$226K Sell
2,578
-585
-18% -$55.1K 0.09% 157
2020
Q2 		$311K Sell
3,163
-1,356
-30% -$119K 0.13% 141
2020
Q1 		$344K Sell
4,519
-887
-16% -$75.6K 0.19% 108
2019
Q4 		$479K Sell
5,406
-4,575
-46% -$380K 0.27% 67
2019
Q3 		$756K Buy
9,981
+488
+5% +$33.5K 0.45% 49
2019
Q2 		$690K Buy
9,493
+703
+8% +$55.3K 0.45% 54
2019
Q1 		$708K Buy
8,790
+7,632
+659% +$624K 0.58% 45
2018
Q4 		$1.07M Buy
+1,158
New +$102K 0.49% 51

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Outlook Wealth Advisors's ABBV Position: Q2 2026 in Review

Outlook Wealth Advisors reduced its AbbVie (ABBV) stake by 3% in Q2 2026, selling an estimated $8.61K and leaving 1,301 shares worth $327K. The position accounts for 0.07% of the portfolio, ranked #239.

Outlook Wealth Advisors first reported a position in ABBV in Q4 2018 and has held it in 25 quarters since. The position peaked at $1.07M in Q4 2018. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Outlook Wealth Advisors held 1,301 shares of AbbVie worth $327K as of Q2 2026.
  • Outlook Wealth Advisors sold 40 AbbVie shares in Q2 2026, an estimated $8.61K.
  • AbbVie made up 0.07% of Outlook Wealth Advisors's portfolio in Q2 2026, its #239 holding.
  • Outlook Wealth Advisors first reported a position in AbbVie in Q4 2018 and has held it in 25 quarters since.
  • Outlook Wealth Advisors's AbbVie position peaked at $1.07M in Q4 2018.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Outlook Wealth Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.